Mixed dementia occurs when a person experiences brain changes caused by more than one type of dementia at the same time. This complex condition requires a careful approach to treatment, combining strategies that address each form of dementia present while supporting the person’s overall quality of life and managing symptoms as they progress.

Understanding Treatment Goals in Mixed Dementia

When someone receives a diagnosis of mixed dementia, the approach to treatment focuses on several important goals. The primary aim is to slow down the progression of the condition as much as possible, while also managing symptoms that affect daily life. Treatment plans are carefully tailored to match the specific types of dementia present in each person, their overall health status, and the stage of disease they are experiencing.^[2]

Because mixed dementia involves multiple disease processes occurring simultaneously in the brain, treatment becomes more complex than addressing a single type of dementia. The most common form involves Alzheimer’s disease (characterized by abnormal protein deposits in the brain) combined with vascular dementia (caused by reduced blood flow to the brain). In some cases, people may also have Lewy bodies (abnormal protein deposits that affect brain function), or even all three conditions at once.^[2]

Medical societies and healthcare organizations have established guidelines for treating dementia, though no specific medications have been approved exclusively for mixed dementia. Instead, doctors rely on treatments developed for individual types of dementia, adapting them to the unique combination present in each patient. At the same time, researchers continue to explore new therapies through clinical trials, searching for more effective ways to address this common but challenging condition.^[8]

The treatment journey involves not just medications, but also lifestyle modifications, management of underlying health conditions, and comprehensive support for both the person with dementia and their caregivers. As the condition progresses through various stages, treatment strategies must evolve to meet changing needs and maintain the best possible quality of life.

Standard Treatment Approaches

Currently, there are no medications specifically approved by regulatory agencies like the U.S. Food and Drug Administration for treating mixed dementia. However, doctors commonly prescribe medications that have been approved for individual types of dementia, particularly Alzheimer’s disease, when symptoms align with that particular condition.^[4]

Medications for Cognitive Symptoms

Healthcare providers may prescribe cholinesterase inhibitors, which are drugs that work by preventing the breakdown of acetylcholine, a chemical messenger important for memory and thinking. These medications include donepezil (also known by the brand name Aricept), galantamine (Reminyl), and rivastigmine (Exelon). These drugs can help improve memory, thinking, and communication abilities in some people, though they do not stop the disease from progressing.^[8][17]

Another medication sometimes used is memantine, which works differently from cholinesterase inhibitors. Memantine blocks a substance called glutamate that, in excessive amounts, can damage brain cells. This medication may be particularly helpful when vascular changes contribute to dementia symptoms. Studies have explored its use in vascular dementia, one of the key components of mixed dementia, though results have been mixed regarding its overall effectiveness.^[8][17]

It’s important to understand that these medications are typically used in people who have been diagnosed with Alzheimer’s disease combined with vascular dementia or other forms of mixed dementia. The decision to prescribe them depends on which symptoms are most prominent and which type of dementia appears to be having the greatest impact on the person’s daily functioning.

Managing Vascular Risk Factors

A crucial part of treating mixed dementia involves addressing problems with blood vessels and circulation, especially when vascular dementia is one of the conditions involved. This approach aims to prevent additional damage to the brain from strokes or reduced blood flow.^[13]

Doctors typically prescribe medications to control high blood pressure, as uncontrolled hypertension can damage blood vessels in the brain and worsen dementia symptoms. Similarly, medications called statins may be given to manage high cholesterol, reducing the risk of fatty deposits blocking blood vessels. To prevent dangerous blood clots from forming, doctors often recommend low-dose aspirin or clopidogrel, or sometimes stronger blood thinners like warfarin, particularly for people who have had strokes or have heart rhythm problems called atrial fibrillation.^[13]

For people with diabetes, maintaining good blood sugar control through medication is essential, as diabetes can damage blood vessels throughout the body, including those in the brain. This comprehensive approach to managing cardiovascular health is not just about treating dementia symptoms—it’s about preventing the condition from worsening more rapidly.^[18]

Medications for Behavioral and Psychological Symptoms

As mixed dementia progresses, many people experience distressing symptoms beyond memory and thinking problems. These can include severe agitation, aggression, anxiety, depression, and hallucinations. When these symptoms become dangerous or cause significant distress, doctors may consider additional medications.^[13]

Antipsychotic medicines such as haloperidol or risperidone may be prescribed when a person shows persistent aggression or extreme distress that puts them or others at risk of harm. However, these medications carry risks, particularly for older adults, including increased chances of stroke and other serious complications. Because of these concerns, a specialist such as a consultant psychiatrist should be involved in the decision to use these drugs, and they should only be given when absolutely necessary and for the shortest time possible.^[13]

For depression, which commonly occurs alongside dementia, antidepressant medications may be appropriate. Treating depression can significantly improve quality of life and may even help with some cognitive symptoms, as depression itself can affect memory and concentration.

Duration and Monitoring of Treatment

Treatment for mixed dementia is typically long-term and requires ongoing adjustment. Medications for managing blood pressure, cholesterol, and blood sugar are usually continued indefinitely, with regular monitoring to ensure they remain effective and are not causing harmful side effects. Cognitive medications like donepezil or memantine are often continued as long as they appear to provide benefit, though their effectiveness may change as the disease progresses.

Healthcare providers schedule regular reviews to assess whether treatments are working, to monitor for side effects, and to adjust doses or change medications as needed. These appointments also provide opportunities to discuss new symptoms, concerns about care, and whether additional support services might be helpful.

Possible Side Effects

Like all medications, those used to treat mixed dementia can cause unwanted effects. Cholinesterase inhibitors may cause nausea, vomiting, diarrhea, loss of appetite, and sleep disturbances in some people. These side effects often improve over time or can be managed by adjusting the dose. Memantine generally causes fewer side effects but may lead to dizziness, headache, or confusion in some individuals.^[8]

Medications used to manage vascular risk factors also carry potential side effects. Blood pressure medications can cause dizziness or fatigue, statins may cause muscle aches, and blood thinners increase the risk of bleeding. Regular monitoring helps doctors identify problems early and make necessary adjustments to keep treatment as safe and effective as possible.

Treatment in Clinical Trials

While standard treatments can help manage symptoms of mixed dementia, researchers around the world are actively working to develop new and more effective therapies. Clinical trials represent the frontier of this research, testing innovative approaches that may one day become standard treatments. Understanding what happens in these trials can help people with mixed dementia and their families make informed decisions about whether participating might be right for them.

Understanding Clinical Trial Phases

Clinical trials typically proceed through several stages, each designed to answer specific questions about a potential treatment. Phase I trials focus primarily on safety, involving small numbers of participants to determine whether a new drug or therapy is safe enough to continue studying. These trials help identify the appropriate dose range and watch for serious side effects.

Phase II trials involve larger groups of people and begin to evaluate whether the treatment actually works—that is, whether it has the desired effect on the disease or symptoms. Researchers also continue to monitor safety and side effects during this phase. Phase III trials are even larger studies that compare the new treatment directly with existing standard treatments or with a placebo (an inactive substance). These trials provide the strongest evidence about whether a new treatment is truly effective and safe enough to be approved for general use.^[7]

Approaches Being Studied in Clinical Trials

Because mixed dementia involves multiple disease processes, researchers are exploring various types of treatments. Some studies focus on medications originally developed for individual types of dementia, such as Alzheimer’s disease or vascular dementia, to see whether they might benefit people with mixed dementia. For instance, clinical trials have examined cholinesterase inhibitors and memantine in people with combinations of dementia types, seeking to understand whether these drugs work differently when multiple forms of brain pathology are present.^[8]

Other research focuses on protecting blood vessels in the brain and improving blood flow. Medications being studied include nimodipine, a drug that affects calcium channels in blood vessels and may help protect brain cells from damage caused by reduced blood flow. Some trials have also looked at hydergine and nicergoline, drugs that may improve blood circulation in the brain, though evidence for their effectiveness remains limited.^[17]

Researchers have also investigated CDP-choline (also called citicoline), a substance naturally found in the body that plays a role in brain cell membranes and neurotransmitter production. The theory is that supplementing with CDP-choline might help protect brain cells and support their function, though more research is needed to confirm whether this approach truly benefits people with mixed dementia.^[17]

Another area of research involves folic acid and other B vitamins. Some studies have explored whether these vitamins, which help control levels of a substance called homocysteine in the blood, might reduce the risk of brain damage or slow dementia progression. High homocysteine levels have been linked to increased risk of vascular problems, so reducing these levels might potentially help protect the brain.^[17]

Non-Medication Approaches in Clinical Research

Not all clinical trials focus on drugs. Some research examines non-pharmacological interventions that might help people with mixed dementia. Cognitive stimulation therapy involves structured activities and exercises designed to improve memory, problem-solving skills, and language. Research has shown that regular participation in mentally stimulating activities may help maintain cognitive function for longer periods.^[14]

Studies have also looked at validation therapy, an approach that focuses on acknowledging and accepting the emotions and experiences of people with dementia rather than correcting their statements or attempting to reorient them to reality. While this approach is used in many care settings, researchers continue to study its effectiveness in reducing distress and improving quality of life.^[17]

Physical exercise programs are another focus of clinical research. Studies consistently suggest that regular physical activity may help slow cognitive decline, improve mood, and maintain physical function in people with various types of dementia. Trials are exploring what types, intensity, and duration of exercise provide the most benefit for people with mixed dementia specifically.

Participating in Clinical Trials

Clinical trials for dementia research are conducted in many locations, including the United States, Europe, and other regions around the world. Eligibility to participate varies depending on the specific trial but typically includes factors such as the type and stage of dementia, age, overall health status, and current medications. Some trials specifically seek participants with mixed dementia, while others may include people with various types of dementia.^[7]

People considering clinical trial participation should discuss this option thoroughly with their healthcare provider. Trials offer potential benefits, including access to new treatments before they become widely available and close medical monitoring by research teams. However, they also involve uncertainties—the new treatment may not work better than existing options, may cause unexpected side effects, or may require frequent visits and tests that can be burdensome.

Early Results and Promising Directions

While many treatments being studied in clinical trials show promise in early phases, it’s important to understand that positive results in small studies don’t always translate to proven benefits in larger trials. The research process takes time, and many potential treatments that seem promising initially do not ultimately prove effective enough to be approved for general use.

Current research increasingly recognizes that mixed dementia is more common than previously thought, particularly in older adults. Autopsy studies have revealed that more than half of people over age 80 with dementia have changes in their brain consistent with multiple types of dementia occurring simultaneously. This growing awareness is driving more focused research specifically addressing mixed dementia rather than treating it simply as separate conditions.^[2][5]

Researchers are also working to develop better ways to diagnose mixed dementia in living individuals. Currently, definitive diagnosis often only comes after death, when brain tissue can be examined directly. New imaging techniques and blood tests for specific biomarkers may eventually allow doctors to identify multiple types of brain pathology earlier and more accurately, leading to more targeted treatments.

Most common treatment methods

• Cholinesterase inhibitors
  • Donepezil (Aricept), galantamine (Reminyl), and rivastigmine (Exelon) help prevent breakdown of acetylcholine, a brain chemical important for memory and thinking
  • May improve cognitive symptoms in people with mixed dementia, particularly when Alzheimer’s disease is one of the components
  • Used for long-term treatment with regular monitoring for effectiveness and side effects
• NMDA receptor antagonists
  • Memantine blocks excessive glutamate, which can damage brain cells
  • May be particularly helpful when vascular changes contribute to dementia symptoms
  • Generally causes fewer side effects than cholinesterase inhibitors
• Cardiovascular medications
  • Antihypertensive drugs to control high blood pressure and protect brain blood vessels
  • Statins to manage high cholesterol and reduce risk of vascular blockages
  • Antiplatelet drugs (aspirin, clopidogrel) or anticoagulants (warfarin) to prevent blood clots
  • Diabetes medications to maintain healthy blood sugar levels
• Behavioral and psychiatric medications
  • Antipsychotic medications for severe agitation or aggression when there is risk of harm, used with caution and specialist oversight
  • Antidepressants for treating depression that commonly occurs with dementia
  • Used only when necessary due to potential risks, particularly in older adults
• Cognitive and behavioral therapies
  • Cognitive stimulation activities and exercises to maintain memory, problem-solving, and language skills
  • Occupational therapy to help with daily living tasks and maintain independence
  • Speech and language therapy for communication difficulties
  • Physical therapy to maintain mobility and prevent falls
• Complementary approaches
  • Regular physical exercise programs to maintain cognitive function and overall health
  • Music therapy, art therapy, and other creative activities for engagement and enjoyment
  • Relaxation techniques such as massage and aromatherapy
  • Structured daily routines and memory aids to support daily functioning